180
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Prospective Study of Morbidity Associated with Snakebite Envenomation

ARTICLE

&
Pages 125-130 | Published online: 04 Sep 2003
 

Abstract

Background: The morbidity associated with snakebite envenomation has not been well documented.

Method: Using a standardized questionnaire all patients with snakebite reported to a regional poison center during the year 2001 were followed after hospital discharge by telephone until resolution of symptoms.

Results: One hundred and twenty-eight snakebite cases were reported, of which 16 (12.5%) were lost to follow-up and 31 (24.2%) reported no progression of symptoms beyond puncture and were deemed “dry bites.” Eighty-one (63.3%) patients were followed for the duration of symptoms. Age ranged from 1 to 86 years with a mean of 32 years. There were 64 males (79%). The snakes were identified as copperhead (n=57), unidentified venomous (n=17), timber rattlesnake (n=6), and cottonmouth (n=1). All patients were initially evaluated in a hospital emergency department of which 51 were admitted. Nine patients received antivenin. Of the 37 patients who had a job, 33 lost a mean of 14 days of work (SD±18.1). Mean duration of edema was reported as 11.4 days (S.D±12). Recurrent edema frequently occurred with limb activity. Pain was scored on a scale of 1 to 10, with a mean score of 4.8 (SD±2.7). Mean duration of pain was reported as 7.8 days (SD±6.4). Thirty patients required accommodation for ambulation including crutches (n=11), limp (n=11), and no shoes or loose shoes (n=14). Of the 26 patients bitten on the hand or finger, duration of reduced function persisted for a mean of 14.3 days (SD±10.4) and reduction of hand strength persisted for a mean of 22 days (SD±25.5). Five patients had poorly healing wounds at the bite site which persisted from 14 to 77 days with a mean of 45 days (SD±22.8)

Conclusion: In this study snakebite resulted in significant duration and extent of morbidity in a majority of patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.